Kathy L. Hudson, PhD,


Dr. Hudson became the People-Centered Research Foundation’s first CEO in August 2017. She is the former Deputy Director for Science, Outreach, and Policy at the National Institutes of Health (NIH) where she led the science policy, legislation, communications, and outreach efforts of the NIH and served as senior advisor to the NIH director. She directed the agency’s efforts to advance biomedical science through policy development and innovative projects and partnerships. Dr. Hudson created major new strategic and scientific initiatives including the National Center for Advancing Translational Sciences, the BRAIN Initiative, the NIH Precision Medicine Initiative, and the Cancer Moonshot. She led the development of major policies that enable science to advance more rapidly including enhancing clinical trials, data sharing, and participation of patients as partners in research. She was the key NIH architect responsible for modernizing the regulations governing research with human subjects.

Dr. Hudson’s professional experience includes serving as the Acting Deputy Director of the National Center for Advancing Translational Sciences, NIH; the NIH Chief of Staff; the Assistant Director of the National Human Genome Research Institute, NIH; and the founder and Director of the Genetics and Public Policy Center at John Hopkins University. Also at Hopkins, Dr. Hudson was an Associate Professor in the Berman Institute of Bioethics, Institute of Genetic Medicine, and Department of Pediatrics.

Dr. Hudson holds a Ph.D. in Molecular Biology from the University of California at Berkeley, an M.S. in Microbiology from the University of Chicago, and a B.A. in Biology from Carleton College.


Richard Turman, M.P.P.,


Richard Turman joined the People-Centered Research Foundation as Chief Operating Officer in May 2018. Mr. Turman is a seasoned management executive with broad expertise across diverse federal organizations. He has held career Senior Executive Service (SES) positions at the White House Office of Management and Budget, National Institutes of Health (NIH), U.S. Health and Human Services (HHS), and the U.S. Food and Drug Administration (FDA). Prior to joining the People-Centered Research Foundation, Mr. Turman served as the founding deputy director of the FDA’s Center for Tobacco Products, a role he held since July 2012. In that capacity, he helped marshal the center’s staff and funding resources to best wield its broad regulatory powers in a way that reduced the death and disease caused by tobacco use. During his tenure, he helped the Center continue to increase from 2 FTE in 2010 to 800+ FTE today and wisely using their $600+ million in annual user fees to fund important regulatory science, robust compliance and enforcement efforts nationwide, and effective advertising campaigns to curb youth nicotine addiction.

Prior to his service at FDA, Mr. Turman served as HHS’ principal deputy assistant secretary for Financial Resources where he was responsible for developing and managing the department’s then-$900 billion budget, as well as more than 75,000 grants and 31,000 acquisitions. Before that, Mr. Turman was HHS’ deputy assistant secretary for Budget, where he led HHS’ successful transition from the George W. Bush administration to the Barack Obama administration. Mr. Turman has also held roles as associate director for Budget at NIH and director of Federal Relations at the Association of American Universities. He served as branch chief at the White House office of Management and Budget for five years, where he supervised a team of examiners as they reviewed and helped formulate the budgetary, legislative, regulatory, performance, and management policies of HHS’ Public Health Service agencies.

Mr. Turman earned his M.P.P. from the Goldman School of Public Policy at the University of California, Berkeley and a bachelor of arts from the University of California, Santa Cruz. He was awarded the SES Presidential Rank Award of Meritorious Executive in 2009 and the SES Presidential Rank Award of Distinguished Executive in 2012, having been nominated for the awards by successive Administrations.


Michelle A. Culp, M.P.H., 


Michelle Culp joined the People-Centered Research Foundation as Chief Scientific Officer in October 2017. Ms. Culp brings a wealth of experience and expertise in clinical research operations and clinical trial management, serving as the Director of Clinical Operations at the NIH National Center for Advancing Translational Science and as the Acting Director of the Trial Innovation Network. She developed and managed innovative and efficient approaches to clinical operations for the Clinical and Translational Science Awards (CTSA) Program and NCATS. She has extensive experience managing clinical trial operations for NIH and industry studies. Ms. Culp was on special assignment with the NIH Office of Science Policy, working on clinical trial stewardship reforms, including the NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research, the NIH Policy on Good Clinical Practice Training and other NIH clinical trial stewardship reforms.

Ms. Culp earned her M.P.H. from the Johns Hopkins School of Public Health and a bachelor of science in nursing from the University of Maryland. Prior to coming to NCATS, she was the director of the Office of Clinical Trials Operations and Management for the National Institute of Dental and Craniofacial Research, where she oversaw intramural and extramural clinical research. Before that, Ms. Culp was Chief of the Office of Clinical Research Affairs in the Division of Microbiology and Infectious Diseases at the National Institute of Allergy and Infectious Diseases, where she oversaw the clinical operations for numerous biodefense, influenza vaccine and other global infectious disease trials. She has worked for private pharmaceutical and contract research companies providing clinical trial services, clinical monitoring and project management.



PCRF board members include:

  • Richard Bankowitz, MD, MBA, FACP, Executive Vice President, Clinical Affairs, America’s Health Insurance Plans (AHIP)
  • Josephine P. Briggs, MD, Director, National Center for Complementary and Integrative Health (NCCIH)
  • Marc M. Boutin, JD, Chief Executive Officer, National Health Council (NHC)
  • Robert Califf, MD, former FDA Commissioner and Professor of Cardiology at Duke
  • Donna Cryer, President and CEO of the Global Liver Institute
  • Craig Lipset, MPH, Head of Clinical Innovation, Global Product Development, Pfizer
  • Reed Tuckson, MD, FACP, Managing Director of Tuckson Health Connections
  • Joanne Waldstreicher, MD, Chief Medical Officer, Johnson & Johnson